Bioequivalence Study of Epalrestat for Healthy Chinese Subjects

Yang, DD; Wang, XD; Duan, Y; Xu, YC; Ruan, ZR; Jiang, B; Lou, HG; Chen, JL

Chen, JL (通讯作者),Zhejiang Univ, Ctr Clin Pharmacol, Sch Med, Affiliated Hosp 2, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023; ():

Abstract

Epalrestat is a reversible noncompetitive inhibitor of aldose reductase with selective inhibition of aldose reductase. It can inhibit the accumulation......

Full Text Link